Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Sun pharma

    Tag: Sun Pharma

    You Searched For "Sun pharma"
    Sun Pharma: USFDA classifies Halol facility as Official Action Indicated

    Sun Pharma: USFDA classifies Halol facility as Official Action Indicated

    Medical Dialogues Bureau30 March 2020 1:18 PM IST
    Mumbai: Sun Pharma has announced that the company has received communication from the USFDA indicating that the Halol facility has been classified as...
    Sun Pharma nod to Rs 1,700 crore share buy-back offer at Rs 425 each

    Sun Pharma nod to Rs 1,700 crore share buy-back offer at Rs 425 each

    Medical Dialogues Bureau17 March 2020 5:18 PM IST
    New Delhi: Indian Drug giant Sun Pharmaceutical Industries has announced that its board has approved Rs 1,700 crore share buyback offer at a...
    Shortage of generic version of BP drug pindolol, says Sun Pharma

    Shortage of generic version of BP drug pindolol, says Sun Pharma

    Medical Dialogues Bureau3 March 2020 12:36 PM IST
    The coronavirus outbreak has disrupted international businesses dependent on Chinese supplies and industry experts expect Indian generic drugmakers to...
    CDSCO flags 34 drugs for failing quality test; Details

    CDSCO flags 34 drugs for failing quality test; Details

    Farhat Nasim15 Feb 2020 11:40 AM IST
    New Delhi: The apex drug regulator, Central Drugs Standard Control Organization (CDSCO) has flagged 34 batches of medicines for failing quality...
    Sun Pharma arm- SPARC application for cancer drug Taclantis rejected by USFDA

    Sun Pharma arm- SPARC application for cancer drug Taclantis rejected by USFDA

    Medical Dialogues Bureau12 Feb 2020 1:10 PM IST
    "The company has received a Complete Response Letter (CRL) from the United States Food & Drug Administration (USFDA) for the new drug application...
    Sun Pharma reports Rs 6923.40 crore total expenses in Q3

    Sun Pharma reports Rs 6923.40 crore total expenses in Q3

    Farhat Nasim7 Feb 2020 4:43 PM IST
    New Delhi: Drug major Sun Pharmaceutical Industries on Thursday reported a 26.43 per cent decline in its consolidated net profit to Rs 913.52 crore...
    Sun Pharma unveils acne drug Absorica LD in US

    Sun Pharma unveils acne drug Absorica LD in US

    Medical Dialogues Bureau5 Feb 2020 11:41 AM IST
    "The launch of Absorica LD - which offers the proven efficacy and safety of Absorica at a lower dose - underscores our commitment to making a...
    Sun Pharma, Rockwell Medical ink licensing pact for Triferic in India

    Sun Pharma, Rockwell Medical ink licensing pact for Triferic in India

    MD bureau16 Jan 2020 10:30 AM IST
    As per the terms of the agreement, Sun Pharma will be the exclusive development and commercialisation partner for Triferic during the term of the...
    Sun Pharma plea to refix price of Ciprofloxacin Hydrochloride Injection rejected

    Sun Pharma plea to refix price of Ciprofloxacin Hydrochloride Injection rejected

    Farhat Nasim6 Jan 2020 1:15 PM IST
    New Delhi: In a major setback to Ranbaxy Laboratories Limited (now Sun Pharmaceutical Industries Ltd.), the Department of Pharmaceuticals (DoP) has...
    NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

    NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

    Medical Dialogues Bureau15 Nov 2019 4:29 PM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    NPPA fixes retail price of 14 drug formulations; Details

    NPPA fixes retail price of 14 drug formulations; Details

    Farhat Nasim13 Nov 2019 11:23 AM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    Sun Pharma carried out off-label promotions of 3 drugs-Ilumya, Yonsa, Absorica, alleges former employee

    Sun Pharma carried out off-label promotions of 3 drugs-Ilumya, Yonsa, Absorica, alleges former employee

    Farhat Nasim10 Nov 2019 5:37 PM IST
    New Delhi: In a major setback to the country's largest drugmaker Sun Pharmaceuticals Ltd. (Sun Pharma), the firm has been accused of allegedly...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok